RAGE gene polymorphism and environmental factor in the risk of oral cancer

Journal of Dental Research

Volumn 94, Issue 3, 2015, Pages 403-411

  Su, S ^a   Chien, M ^b,c   Lin, C ^d,e   Chen, M ^d,f   Yang, S ^d,e  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

betel quid; haplotype; oral squamous cell carcinoma; receptor for advanced glycosylation endproducts; single nucleotide polymorphisms; tobacco

Indexed keywords

ADENINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; CYTOSINE; GLYCINE; GUANINE; IMMUNOGLOBULIN RECEPTOR; SERINE; THYMINE;

ADVERSE EFFECTS; ARECA; BASE PAIRING; CANCER STAGING; CARCINOGENESIS; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HUMAN; MALE; MIDDLE AGED; MOUTH TUMOR; NUCLEOTIDE SEQUENCE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TOBACCO USE;

ADENINE; ARECA; BASE PAIRING; BASE SEQUENCE; CARCINOGENESIS; CASE-CONTROL STUDIES; CYTOSINE; FEMALE; GENE FREQUENCY; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GLYCINE; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANINE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; RISK FACTORS; SEQUENCE DELETION; SERINE; THYMINE; TOBACCO USE;

EID: 84924761561     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034514566215     Document Type: Article

References (40)

1. Awang MN. Betel quid and oral carcinogenesis. Singapore Med J. 1988 ; 29: 589-593
2. Bharti V, Mohanti BK, Das SN. Functional genetic variants of CTLA-4 and risk of tobacco-related oral carcinoma in high-risk North Indian population. Hum Immunol. 2013 ; 74: 348-352
3. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl). 2005 ; 83: 876-886
4. Chung TT, Pan MS, Kuo CL, Wong RH, Lin CW, Chen MK, Yang SF. Impact of RECK gene polymorphisms and environmental factors on oral cancer susceptibility and clinicopathologic characteristics in Taiwan. Carcinogenesis. 2011 ; 32: 1063-1068
5. Clynes R, Moser B, Yan SF, Ramasamy R, Herold K, Schmidt AM. Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response. Curr Mol Med. 2007 ; 7: 743-751
6. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC Cancer Staging Manual and the future of TNM. Ann Surg Oncol. 2010 ; 17: 1471-1474
7. Gu H, Yang L, Sun Q, Zhou B, Tang N, Cong R, Zeng Y, Wang B.. Gly82Ser polymorphism of the receptor for advanced glycation end products is associated with an increased risk of gastric cancer in a Chinese population. Clin Cancer Res. 2008 ; 14: 3627-3632
8. Gupta K, Metgud R.. Evidences suggesting involvement of viruses in oral squamous cell carcinoma. Patholog Res Int. 2013 ; 2013: 642496
9. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet. 2005 ; 6: 95-108
10. Hofmann MA, Drury S, Hudson BI, Gleason MR, Qu W, Lu Y, Lalla E, Chitnis S, Monteiro J, Stickland MH, et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 2002 ; 3: 123-135
11. Hudson BI, Stickland MH, Grant PJ. Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes. 1998 ; 47: 1155-1157
12. Hudson BI, Stickland MH, Futers TS, Grant PJ. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes. 2001 ; 50: 1505-1511
13. Jadhav KB, Gupta N.. Clinicopathological prognostic implicators of oral squamous cell carcinoma: need to understand and revise. N Am J Med Sci. 2013 ; 5: 671-679
14. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008 ; 58: 71-96
15. Landesberg R, Woo V, Huang L, Cozin M, Lu Y, Bailey C, Qu W, Pulse C, Schmidt AM. The expression of the receptor for glycation endproducts (RAGE) in oral squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 ; 105: 617-624
16. Lee LA, Huang CG, Tsao KC, Liao CT, Kang CJ, Chang KP, Huang SF, Chen IH, Fang TJ, Li HY, et al. Increasing rates of low-risk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: association with clinical outcomes. J Clin Virol. 2013 ; 57: 331-337
17. Lunetta KL. Genetic association studies. Circulation. 2008 ; 118: 96-101
18. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Elliston K, Stern D, Shaw A.. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem. 1992 ; 267: 14998-15004
19. Park S, Yoon SJ, Tae HJ, Shim CY. RAGE and cardiovascular disease. Front Biosci (Landmark Ed). 2011 ; 16: 486-497
20. Qian F, Sun BL, Zhang WY, Ke J, Zhu J.. Gly82Ser polymorphism of the receptor for advanced glycation end-product (RAGE) potential high risk in patients with colorectal cancer. Tumour Biol. 2014 ; 35: 3171-3175
21. Ramasamy R, Yan SF, Schmidt AM. RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts. J Leukoc Biol. 2009 ; 86: 505-512
22. Schenk S, Schraml P, Bendik I, Ludwig CU. A novel polymorphism in the promoter of the RAGE gene is associated with non-small cell lung cancer. Lung Cancer. 2001 ; 32: 7-12
23. Schmidt AM, Stern D.. Atherosclerosis and diabetes: the RAGE connection. Curr Atheroscler Rep. 2000 ; 2: 430-436
24. Scully C, Bagan J.. Oral squamous cell carcinoma overview. Oral Oncol. 2009 ; 45 (4-5). 301-308
25. Scully C, Field JK, Tanzawa H.. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol. 2000 ; 36: 256-263
26. Sparvero LJ, Asafu-Adjei D, Kang R, Tang D, Amin N, Im J, Rutledge R, Lin B, Amoscato AA, Zeh HJ, et al. RAGE (receptor for advanced glycation endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med. 2009 ; 7: 17
27. Stephens M, Scheet P.. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet. 2005 ; 76: 449-462
28. Sterenczak KA, Nolte I, Murua Escobar H.. RAGE splicing variants in mammals. Methods Mol Biol. 2013 ; 963: 265-276
29. Sugaya K, Fukagawa T, Matsumoto K, Mita K, Takahashi E, Ando A, Inoko H, Ikemura T.. Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics. 1994 ; 23: 408-419
30. Supic G, Jovic N, Kozomara R, Zeljic K, Magic Z.. Interaction between the MTHFR C677T polymorphism and alcohol: impact on oral cancer risk and multiple DNA methylation of tumor-related genes. J Dent Res. 2011 ; 90: 65-70
31. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature. 2000 ; 405 (6784). 354-360
32. Taniyama Y, Takeuchi S, Kuroda Y.. Genetic polymorphisms and oral cancer. J UOEH. 2010 ; 32: 221-236
33. Tesarova P, Kalousová M, Jáchymová M, Mestek O, Petruzelka L, Zima T.. Receptor for advanced glycation end products (RAGE): soluble form (sRAGE) and gene polymorphisms in patients with breast cancer. Cancer Invest. 2007 ; 25: 720-725
34. Vissing H, Aagaard L, Tommerup N, Boel E.. Localization of the human gene for advanced glycosylation end product-specific receptor (AGER) to chromosome 6p21.3. Genomics. 1994 ; 24: 606-608
35. Xie J, Mendez JD, Mendez-Valenzuela V, Aguilar-Hernandez MM. Cellular signalling of the receptor for advanced glycation end products (RAGE). Cellular Signal. 2013 ; 25: 2185-2197
36. Xu Q, Xue F, Yuan B, Zhang L, Li J, He Z.. The interaction between RAGE gene polymorphisms and HPV infection in determining the susceptibility of cervical cancer in a Chinese population. Cancer Biomark. 2012 ; 11: 147-153
37. Yan SF, Ramasamy R, Schmidt AM. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response. J Mol Med (Berl). 2009 ; 87: 235-247
38. Yan SF, Yan SD, Ramasamy R, Schmidt AM. Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation. Ann Med. 2009 ; 41: 408-422
39. Zhang S, Hou X, Zi S, Wang Y, Chen L, Kong B.. Polymorphisms of receptor for advanced glycation end products and risk of epithelial ovarian cancer in Chinese patients. Cell Physiol Biochem. 2013 ; 31: 525-531
40. Zini A, Czerninski R, Sgan-Cohen HD. Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med. 2010 ; 39: 299-305